1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immunophenotypic lineage assessment by multiparameter flow cytometry provides more precise MDS prognosis
    Meeting Abstract

    Onyekwere, I.; Garcia, J. P.; Menghrajani, K.; Chan, A.; Famulare, C.; Patel, M. A.; Philip, J.; Tallman, M. S.; Klimek, V. M.; Levine, R. L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Infusion-related reactions (IRRs) in the DREAMM-2 Study of single-agent belantamab mafodotin (belamaf) in patients with relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Nooka, A.; Lee, H. C.; Badros, A. Z.; Voorhees, P.; Hultcrantz, M.; Karlin, L.; Arnulf, B.; Richardson, P. G.; Zhi, E.; Baron, J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • A multi-center, dose-finding study to assess safety, tolerability, pharmacokinetics and preliminary efficacy of a novel IRAK4 inhibitor CA-4948 in combination with ibrutinib, in patients with relapsed or refractory hematologic malignancies
    Meeting Abstract

    Nowakowski, G. S.; Leslie, L. A.; Joffe, E.; Rosenthal, A. C.; Lunning, M. A.; Patel, K.; Mead, M.; Landsburg, D. J.; Fenske, T. S.; Ramchandren, R.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Safety, pharmacokinetics and activity of CA-4948, an IRAK4 inhibitor, for treatment of patients with relapsed or refractory hematologic malignancies: Results from the phase 1 study
    Meeting Abstract

    Nowakowski, G. S.; Leslie, L. A.; Younes, A.; Rosenthal, A. C.; Lunning, M. A.; Patel, K.; Landsburg, D. J.; Martinez, E.; von Roemeling, R.; Lieberman, C.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Whole-genome sequencing reveals evidence of two biologically and clinically distinct entities: Progressive versus stable myeloma precursor disease
    Meeting Abstract

    Oben, B.; Froyen, G.; Maclachlan, K. H.; Zheng-Lin, B.; Yellapantula, V.; Abascal, F.; Leongamornlert, D. A.; Derkach, A.; Geerdens, E.; Diamond, B.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • A multi-center biologic assignment trial comparing reduced intensity allogeneic hematopoietic cell transplantation to hypomethylating therapy or best supportive care in patients aged 50-75 with advanced myelodysplastic syndrome: Blood and Marrow Transplant Clinical Trials Network Study 1102
    Meeting Abstract

    Nakamura, R.; Saber, W.; Martens, M. J.; Ramirez, A.; Scott, B. L.; Oran, B.; Leifer, E.; Tamari, R.; Mishra, A.; Maziarz, R. T.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Single-cell multi-omics in human clonal hematopoiesis reveals that DNMT3A R882 mutations perturb early progenitor states through selective hypomethylation
    Meeting Abstract

    Nam, A. S.; Dusaj, N.; Izzo, F.; Murali, R.; Mouhieddine, T. H.; Myers, R. M.; Sotelo, J.; Benbarche, S.; Gaiti, F.; Tahri, S.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic cell transplantation (allo-HCT) in T-cell prolymphocytic leukemia (T-PLL): An analysis from the CIBMTR
    Meeting Abstract

    Murthy, H. S.; Ahn, K. W.; Estrada-Merly, N.; Gowda, L.; Dholaria, B.; Bal, S.; Alkhateeb, H. B.; Jagadeesh, D.; Oran, B.; Nakamura, R.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • HORIZON (OP-106): Melflufen plus dexamethasone (dex) in patients (pts) with relapsed/refractory multiple myeloma (RRMM)-analysis of adverse events related to hospitalizations
    Meeting Abstract

    Nadeem, O.; Richardson, P. G.; Mateos, M. V.; Oriol, A.; Larocca, A.; Creixenti, J. B.; Rodríguez-Otero, P.; Leleu, X.; Norkin, M.; Hiemenz, J. W.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Characterization and outcomes in patients with mogamulizumab-associated skin reactions in the MAVORIC trial
    Meeting Abstract

    Musiek, A. C. M.; Whittaker, S.; Horwitz, S. M.; Bagot, M.; Huen, A.; Fisher, D. C.; Haun, P.; Vermeer, M. H.; Ito, T.; Dwyer, K.; more...
    Blood (2020)

    Fulltext@MSK | Save